Emiel J.T. Rutgers, MD, PhD; Lajos Pusztai, MD, PhD; René Bernards, PhD
Potential Financial Conflicts of Interest: Dr. Bernards is an employee of Agendia BV, which invented and developed the MammaPrint breast cancer prognosis test.
Rutgers EJ, Pusztai L, Bernards R. Are Short-Term or Long-Term Recurrence Rates More Important in Breast Cancer Screening?. Ann Intern Med. ;149:357. doi: 10.7326/0003-4819-149-5-200809020-00014
Download citation file:
Published: Ann Intern Med. 2008;149(5):357.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use